[Form 4] GE HealthCare Technologies Inc. Insider Trading Activity

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. (GEHC) insider report: Taha Kass-Hout, listed as Chief Technology Officer, reported two share dispositions on 09/01/2025 related to withholding to satisfy tax obligations from restricted stock unit vesting. The filings show 1,601 shares disposed at $73.73 and 1,296 shares disposed at $73.73. Following those transactions the report lists 66,246 and 64,950 shares beneficially owned, respectively. The Form 4 was signed by an attorney-in-fact, Frank R. Jimenez, General Counsel and Corporate Secretary, on 09/03/2025.

Positive

• Compliance documented: The reporting person filed a Form 4 and the filing was executed by an authorized attorney-in-fact, showing procedural compliance
• Transaction type clarified: Disposals are explicitly identified as share withholding to satisfy tax obligations from RSU vesting, not discretionary sales

Negative

• Reduced insider holdings: Beneficial ownership decreased as a result of withholding (reported balances of 66,246 and 64,950 shares after the two entries)

Insights

Securities/Equity Analyst

TL;DR: Routine RSU tax-withholding sales by an executive; not a performance signal but reduces reported shares.

The reported disposals are explicitly described as share withholding to cover tax obligations from restricted stock unit vesting, which is a common administrative action and not a discretionary sale for cash. Each transaction lists a price of $73.73 on 09/01/2025 and reduced beneficial ownership to 66,246 and 64,950 shares in the two reported lines. Because the filing describes withholding rather than open-market sale, this transaction is generally considered neutral for valuation analysis and provides limited information about the executive's view of company prospects.

Corporate Governance Expert

TL;DR: Compliance filing documenting tax-withholding at vesting; indicates standard insider reporting and delegated signature.

The Form 4 identifies the reporting person as Chief Technology Officer and records share disposals explicitly as tax-withholding tied to RSU vesting. The signature block shows an attorney-in-fact, which is an accepted practice for timely filings. There are no indications in the document of unusual timing, large opportunistic sales, or additional contingent arrangements. This appears to be routine governance and compliance activity rather than a material corporate action.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kass-Hout Taha

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	09/01/2025		F		1,601(1)	D	$73.73	66,246	D
Common Stock, par value $0.01 per share	09/01/2025		F		1,296(1)	D	$73.73	64,950	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did GEHC insider Taha Kass-Hout report on the Form 4?

The Form 4 reports two dispositions on 09/01/2025 of 1,601 and 1,296 shares at $73.73 each, described as withholding to satisfy tax obligations from RSU vesting.

Why were the shares disposed according to the filing?

The filing explicitly states the disposals were for withholding of shares to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

What is Taha Kass-Hout's role at GEHC as listed in the filing?

The filing lists Taha Kass-Hout as an Officer with the title Chief Technology Officer.

When was the Form 4 signed and by whom?

The Form 4 shows a signature executed by Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact on 09/03/2025.

How many shares did the reporting person beneficially own after the transactions?

Following the reported transactions the filing lists beneficial ownership of 66,246 shares and 64,950 shares on the two reported lines.